Moreau, P., Joshua, D., Chng, W., Palumbo, A., Goldschmidt, H., Hájek, R., . . . Dimopoulos, M. A. (2017). Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study. Leukemia.
Citação norma ChicagoMoreau, P., et al. "Impact of Prior Treatment On Patients With Relapsed Multiple Myeloma Treated With Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in the Phase 3 ENDEAVOR Study." Leukemia 2017.
Citação norma MLAMoreau, P., et al. "Impact of Prior Treatment On Patients With Relapsed Multiple Myeloma Treated With Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in the Phase 3 ENDEAVOR Study." Leukemia 2017.